We investigated differences in the prevalence of anosognosia and neuropsychiatric symptoms (NPSs) characteristics according to disease severity in patients with early-onset Alzheimer disease (EOAD).
Methods:
We recruited 616 patients with EOAD. We subdivided participants into 2 groups based on the presence or absence of anosognosia and then again by Clinical Dementia Rating (CDR) scale. We compared the differences in the Neuropsychiatric Inventory (NPI) scores according to anosognosia and disease severity.
Results:
The percentage of patients with anosognosia in each CDR group steadily increased as the CDR rating increased (CDR 0.5 8.6% vs CDR 1 13.6% vs CDR 2 26.2%). The NPI total score was significantly higher in patients with anosognosia in the CDR 0.5 and 1 groups; by contrast, it had no association in the CDR 2 group. Frontal lobe functions were associated with anosognosia only in the CDR 0.5 and 1 groups. After stratification by CDR, in the CDR 0.5 group, the prevalence of agitation (P = .040) and appetite (P = .013) was significantly higher in patients with anosognosia. In the CDR 1 group, patients with anosognosia had a significantly higher prevalence of delusions (P = .032), hallucinations (P = .048), and sleep disturbances (P = .047). In the CDR 2 group, we found no statistical difference in the frequency of symptoms between patients with and without anosognosia.
Conclusion:
These results confirm that the prevalence of anosognosia as well as the individual NPS and cognitive functions associated with it differ according to EOAD severity.
MarkovaISBerriosGE. Approaches to the assessment of awareness: conceptual issues. Neuropsychol Rehabil. 2006;16(4):439–455.
2.
ClareLMarkovaIVerheyFKennyG. Awareness in dementia: a review of assessment methods and measures. Aging Ment Health. 2005;9(5):394–413.
3.
AaltenPvan ValenEClareLKennyGVerheyF. Awareness in dementia: a review of clinical correlates. Aging Ment Health. 2005;9(5):414–422.
4.
StarksteinSEJorgeRMizrahiRRobinsonRG. A diagnostic formulation for anosognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2006;77(6):719–725.
5.
MograbiDCFerriCPSosaAL. Unawareness of memory impairment in dementia: a population-based study. Int Psychogeriatr. 2012;24(6):931–939.
6.
ClareLNelisSMMartyrA. The influence of psychological, social and contextual factors on the expression and measurement of awareness in early-stage dementia: testing a biopsychosocial model. Int J Geriatr Psychiatry. 2012;27(2):167–177.
7.
LopezOLBeckerJTSomsakDDewMADeKoskyST. Awareness of cognitive deficits and anosognosia in probable Alzheimer’s disease. Eur Neurol. 1994;34(5):277–282.
8.
HarwoodDGSultzerDLFeilDMonserrattLFreedmanEMandelkernMA. Frontal lobe hypometabolism and impaired insight in Alzheimer disease. Am J Geriatr Psychiatry. 2005;13(11):934–941.
9.
De CarolisACipolliniVCoriglianoV. Anosognosia in people with cognitive impairment: association with cognitive deficits and behavioral disturbances. Dement Geriatr Cogn Dis Extra. 2015;5(1):42–50.
10.
Conde-SalaJLRene-RamirezRTurro-GarrigaO. Clinical differences in patients with Alzheimer’s disease according to the presence or absence of anosognosia: implications for perceived quality of life. J Alzheimers Dis. 2013;33(4):1105–1116.
11.
StarksteinSEJorgeRMizrahiRAdrianJRobinsonRG. Insight and danger in Alzheimer’s disease. Eur J Neurol. 2007;14(4):455–460.
12.
SpallettaGGirardiPCaltagironeCOrfeiMD. Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment. J Alzheimers Dis. 2012;29(4):761–772.
13.
HarwoodDGSultzerDLWheatleyMV. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry Neuropsychol Behav Neurol. 2000;13(2):83–88.
14.
StarksteinSEBrockmanSBruceDPetraccaG. Anosognosia is a significant predictor of apathy in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci. 2010;22(4):378–383.
15.
MakEChinRNgLTYeoDHameedS. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer’s disease. Int J Geriatr Psychiatry. 2015;30(12):1207–1214.
16.
HorningSMMelroseRSultzerD. Insight in Alzheimer’s disease and its relation to psychiatric and behavioral disturbances. Int J Geriatr Psychiatry. 2014;29(1):77–84.
17.
VogelAWaldorffFBWaldemarG. Impaired awareness of deficits and neuropsychiatric symptoms in early Alzheimer’s disease: the Danish Alzheimer Intervention Study (DAISY). J Neuropsychiatry Clin Neurosci. 2010;22(1):93–99.
18.
KashiwaYKitabayashiYNarumotoJNakamuraKUedaHFukuiK. Anosognosia in Alzheimer’s disease: association with patient characteristics, psychiatric symptoms and cognitive deficits. Psychiatry Clin Neurosci. 2005;59(6):697–704.
19.
ParkHKChoiSHParkSA. Cognitive profiles and neuropsychiatric symptoms in Korean early-onset Alzheimer’s disease patients: a CREDOS study. J Alzheimers Dis. 2015;44(2):661–673.
20.
SaFPintoPCunhaC. Differences between early and late-onset Alzheimer’s disease in neuropsychological tests. Front Neurol. 2012;3:81.
21.
ToyotaYIkedaMShinagawaS. Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer’s disease. Int J Geriatr Psychiatry. 2007;22(9):896–901.
22.
ShinagawaSIkedaMToyotaY. Frequency and clinical characteristics of early-onset dementia in consecutive patients in a memory clinic. Dement Geriatr Cogn Disord. 2007;24(1):42–47.
23.
PanegyresPKChenHY. Early-onset Alzheimer’s disease: a global cross-sectional analysis. Eur J Neurol. 2014;21(9):1149–1154.
24.
SpallettaGLucaVDPadovaniA. Early onset versus late onset in Alzheimer’s disease: what is the reliable cut-off?Adv Alzheimers Dis. 2013;2(1):40–47.
25.
PanegyresPKChenHY. Differences between early and late onset Alzheimer’s disease. Am J Neurodegener Dis. 2013;2(4):300–306.
26.
KoedamELLaufferVvan der VliesAEvan der FlierWMScheltensPPijnenburgYA. Early-versus late-onset Alzheimer’s disease: more than age alone. J Alzheimers Dis. 2010;19(4):1401–1408.
27.
KaiserNCMelroseRJLiuC. Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2012;27(7):520–529.
28.
TanakaHHashimotoMFukuharaR. Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer’s disease. Psychogeriatrics. 2015;3(10):12108.
29.
van VlietDde VugtMEAaltenP. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer’s disease—part 1: findings of the two-year longitudinal NeedYD-study. Dement Geriatr Cogn Disord. 2012;34(5-6):319–327.
30.
BeattieAMDaker-WhiteGGilliardJMeansR. Younger people in dementia care: a review of service needs, service provision and models of good practice. Aging Ment Health. 2002;6(3):205–212.
31.
DouradoMCLaksJMograbiD. Functional status predicts awareness in late-onset but not in early-onset Alzheimer disease. J Geriatr Psychiatry Neurol. 2016;29(6):313–319. doi:0891988716640372
32.
van VlietDde VugtMEKohlerS. Awareness and its association with affective symptoms in young-onset and late-onset Alzheimer disease: a prospective study. Alzheimer Dis Assoc Disord. 2013;27(3):265–271.
33.
McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health And Human Services Task Force on Alzheimer’s disease. Neurology. 1984;34(7):939–944.
34.
ParkHKNaDLHanSH. Clinical characteristics of a nationwide hospital-based registry of mild-to-moderate Alzheimer’s disease patients in Korea: a CREDOS (Clinical Research Center for Dementia of South Korea) study. J Korean Med Sci. 2011;26(9):1219–1226.
35.
MorrisJC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–2414.
36.
ChoiSHNaDLKwonHMYoonSJJeongJHHaCK. The Korean version of the Neuropsychiatric Inventory: a scoring tool for neuropsychiatric disturbance in dementia patients. J Korean Med Sci. 2000;15(6):609–615.
37.
CummingsJLMegaMGrayKRosenberg-ThompsonSCarusiDAGornbeinJ. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–2314.
38.
KangYWNaDLHahnSH. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15(2):300–307.
39.
KimJYParkJHLeeJJ. Standardization of the Korean version of the Geriatric Depression Scale: reliability, validity, and factor structure. Psychiatry Investig. 2008;5(4):232–238.
40.
StarksteinSE. Anosognosia in Alzheimer’s disease: diagnosis, frequency, mechanism and clinical correlates. Cortex. 2014;61:64–73.
41.
ClareL. Managing threats to self: awareness in early stage Alzheimer’s disease. Soc Sci Med. 2003;57(6):1017–1029.
42.
MorrisRGMograbiDC. Anosognosia, autobiographical memory and self knowledge in Alzheimer’s disease. Cortex. 2013;49(6):1553–1565.
43.
RosenHJ. Anosognosia in neurodegenerative disease. Neurocase. 2011;17(3):231–241.
44.
MograbiDCFerriCPStewartR. Neuropsychological and behavioral disturbance correlates of unawareness of memory impairment in dementia: a population-based study. J Geriatr Psychiatry Neurol. 2015;28(1):3–11.
45.
AmanzioMVaseLLeottaDMiceliRPalermoSGeminianiG. Impaired awareness of deficits in Alzheimer’s disease: the role of everyday executive dysfunction. J Int Neuropsychol Soc. 2013;19(1):63–72.
46.
AaltenPde VugtMELousbergR. Behavioral problems in dementia: a factor analysis of the Neuropsychiatric Inventory. Dement Geriatr Cogn Disord. 2003;15(2):99–105.
47.
MizrahiRStarkstein SE, JorgeRRobinsonRG. Phenomenology and clinical correlates of delusions in Alzheimer disease. Am J Geriatr Psychiatry. 2006;14(7):573–581.
48.
MigliorelliRPetraccaGTesonASabeLLeiguardaRStarksteinSE. Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer’s disease. Psychol Med. 1995;25(3):505–513.
49.
SultzerDLLeskinLPMelroseRJ. Neurobiology of delusions, memory, and insight in Alzheimer disease. Am J Geriatr Psychiatry. 2014;22(11):1346–1355.
50.
MigliorelliRTesonASabeL. Anosognosia in Alzheimer’s disease: a study of associated factors. J Neuropsychiatry Clin Neurosci. 1995;7(3):338–344.
51.
StarksteinSESabeLChemerinskiEJasonLLeiguardaR. Two domains of anosognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1996;61(5):485–490.
52.
ChiSYuJTTanMSTanL. Depression in Alzheimer’s disease: epidemiology, mechanisms, and management. J Alzheimers Dis. 2014;42(3):739–755.
53.
LyketsosCGOlinJ. Depression in Alzheimer’s disease: overview and treatment. Biol Psychiatry. 2002;52(3):243–252.
